Application of electrospray mass spectrometry in the identification of intact glucuronide and sulphate conjugates of clozapine in rat

Xenobiotica

Volumn 26, Issue 5, 1996, Pages 541-550

  Zhang, G Q ^a   McKay, G ^a   Hubbard, J W ^a   Midha, K K ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

7 GLUCURONYLOXYCLOZAPINE; CLOZAPINE; DRUG METABOLITE; GLUCURONIDE; NORCLOZAPINE; SULFATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG CONJUGATION; DRUG FECES LEVEL; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; THIN LAYER CHROMATOGRAPHY;

EID: 0030012851     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.3109/00498259609046730     Document Type: Article

References (12)

1. FISCHER, V., HAAR, J., GREINER, L., LLOYD, R., and MASON R., 1991, Possible role of free radical formation in clozapine (Clozaril)-induced agranulocytosis. Molecular Pharmacology, 40, 846-853.
2. FITTON, A., and HELL, R., 1990, Clozapine: a review of its pharmacological properties and therapeutic use in the treatment of schizophrenia. Drugs, 40, 722-747.
3. GAUCH, R., and MICHAELIS, W., 1971, The metabolism of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine (clozapine) in mice, dogs and human subjects. Farmaco, 26, 667-681.
4. GERSON, S., and MELTZER, H., 1992, Mechanisms of clozapine induced agranulocytosis. Drug Safety, 7 (suppl. 1), 17-25.
5. KANE, J., HONIGFELD, G., SINGER, J., and MELTZER, H., 1988, Clozapine for the treatment resistant schizophrenic. A double blind comparison with chlorpromazine/benztropine. Archives of General Psychiatry, 45, 789-796.
6. LAMBERT, R., 1965, Surgery of the Digestive System of the Rat, trans. B. Julien (Springfield, Illinois: Charles C. Thomas).
7. LIEBERMAN, J., JOHNS, C., KANE, J., RAI, K., PISCIOTTA, A., SALTZ, B., and HOWARD, A., 1988, Clozapine induced agranulocytosis: non-cross-reactivity with other psychotropic drugs. Journal of Clinical Psychiatry, 49, 271-277.
8. MASON, R., and FISCHER, V., 1992, Possible role of free radical formation in drug-induced agranulocytosis. Drug Safety, 7 (suppl. 1), 45-50.
9. MELTZER, H., BASTANI, B., YOUNG KWON, K., RAMIREZ, L., BURNET, S., and SHARPE, J., 1989, A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report. Psychopharmacology, 99, S68-72.
10. MULDER, G. SCHOLTENS, E., and MEIJER, D., 1981, Collection of metabolites from bile and urine from the rat. Methods in Enzymology, 77, 21-30.
11. UTRECHT, J., 1992, Metabolism of clozapine by neutrophils. Possible implications for clozapine-induced agranulocytosis. Drug Safety, 7 (suppl. 1), 51-56.
12. 3 bei der Metabolisierung des Clozapins im menschlichen Korper. Arzneimittel-Forschung/Drug Research, 27, 982-990.